Table 4. Different CS-based aerogels for pharmaceuticals removala.
| Aerogel | Pharmaceuticals | Initial concentration mg L−1 | pH | Adsorption capacity mg g−1 | Removal % | References |
|---|---|---|---|---|---|---|
| CGC-MOF | IBP | 3 | 7 | — | 99.28% | 108 |
| NPX | 93.39% | |||||
| CCN-AG | DFS | 30 | 4 | 501 | ∼98% | 109 |
| CS@CNC-HTA | SIL | 100 | 6 | 86 | 73% | 52 |
| CPC | 100 | 390 | 90% | |||
| CS | IBP | 100 | 2 | 596 | 83% | 110 |
| Silica/CS | Carbamazepine | 180.42 | 8.5 | 1610 | 96.8% | 111 |
| IBP | 201.92 | 1773 | 95.4% | |||
| Diclofenac | 51.83 | 390 | 97.4% | |||
| CS | RIF | 30 | 7 | 66.91 | — | 112 |
| STM | 11 | |||||
| IBP | 24.21 | |||||
| CS/ABC | KTP | 50 | 4 | 130.29 | — | 113 |
| ZIF-67/QGO/SB-CS | DOX | 10 | — | 1300 | — | 114 |
| TC | 400 | 1375 | ||||
| RFP | 1000 | 100 | ||||
| MNZ | 100 | 300 | ||||
| IBP | 10 | 250 |
a
IBP: ibuprofen; NPX: naproxen; CGC: chitosan–Gelation-composite; MOF: metal organic framework; DFS: diclofenac sodium; CCN: covalent organic polymer-chitosan-aerogel; CNC: cellulose nanocrystals; HTA: hydrophobized tannic acid; SIL: sildenafil citrate; CPC: cetylpyridinium chloride; RIF: rifampicin; STM: streptomycin; ABC: activated biochar; KTP: ketoprofen; TC: tetracycline; DOX: doxorubicin hydrochloride; RFP: rifampicin; MNZ: metronidazole; ZIF: metal–organic framework; QGO: benzoquinone-functionalized GO; SB-CS: sulfobetaine-modified chitosan.